Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Zero Hedge excerpt: "...Instead the research seem

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153814
(Total Views: 933)
Posted On: 09/03/2020 8:05:22 PM
Posted By: dfwl28
Re: FBCoach18 #54073
Zero Hedge excerpt: "...Instead the research seems to confirm that IL-6 and more importantly CCL5 (RANTES) and the CCR5/CCL5 axis is the achilles heel of the cytokine storm. There is only one drug to date that has demonstrated statistically significant results in clinical trials that they can quiet the cytokine storm and take dying off the table. That drug is called leronlimab and it is a subcutaneous shot, like what diabetics take, then you feel better in about 3 days. Trump mentioned this type of treatment in a campaign speech less than two weeks ago. Drug maker CytoDyn is the second company after Gilead to file for an EUA in Mild to Moderate COVID-19. It also filed the equivalent of an EUA in the United Kingdom and is expecting a response shortly.


If the FDA or Operation Warp Speed fails to act in the coming days, one of the most promising treatments in the world may be shipped off to the UK leaving Americans with the highly toxic and ineffective big pharma treatment called remdesivir which was just expanded under an EUA for Mild to Moderate patients. Big pharma clearly doesn’t have the answers and is spending money in all the wrong areas like vaccines and antivirals. We have been brainwashed into thinking a vaccine is the panacea. Yet common sense tells us that COVID-19 is just a more contagious and viral form of influenza and we haven’t been successful in defeating it yet. If we are going to find a treatment that takes dying off the table it's going to come from a development stage company like CytoDyn and not from big pharma. People have a right to try, and a drug with a strong safety profile in over 1000 patients should be approved post haste. "





(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us